Multiple antibiotic resistance and efflux

Current Opinion in Microbiology

Volumn 1, Issue 5, 1998, Pages 516-523

  Nikaido, Hiroshi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEGIBACTERIA;

ABC TRANSPORTER; CARRIER PROTEIN;

ACTIVE TRANSPORT; ANTIBIOTIC RESISTANCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; METABOLISM; MULTIDRUG RESISTANCE; PHYSIOLOGY; REVIEW;

ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA;

EID: 0032173598     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(98)80083-0     Document Type: Article

References (71)

1. Levy SB: Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992, 36:695-703.
2. Paulsen IT, Park JH, Choi PS, Saier MH Jr: A family of Gram-negative outer membrane factors that function in the export of proteins, carbohydrates, drugs and heavy metals from Gram-negative bacteria. FEMS Microbiol Lett 1997, 156:1-8.
3. Dinh T, Paulsen IT, Saier MH Jr: A family of extracytoplasmic proteins that allow transport of large molecules across the outer membranes of Gram-negative bacteria. J Bacteriol 1994, 176:3825-3831.
4. Nikaido H: Multidrug efflux pumps of Gram-negative bacteria. J Bacteriol 1996, 178:5853-5859.
5. Saier MH, Paulsen JH, Sliwinski MK, Pao SS, Skurray RA, Nikaido H: Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J 1998, 12:265-274. Analysis of complete genome sequences of five eubacterial and one archaebacterial species showed that putative drug efflux pumps occur widely. Major facilitator superfamily (MFS) pumps occur in large numbers (18 in E. coli) and very widely (found also in archaebacteria), but RND (resistance-nodulation-division) pumps are limited to Gram-negative eubacteria. Drug transporters occur in only 3 out of 17 subfamilies of MFS; in contrast, all of the RND pumps appear to be exporters of drugs, toxic metal ions, or lipooligosaccharides.
6. Van Veen HW, Venema K, Bolhuis H, Oussenko I, Kok J, Poolman B, Driessen AJM, Konings WN: Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc Natl Acad Sci USA 1996, 93:10668-10672.
7. Van Veen HW, Callaghan R, Soceneantu L, Sardini A, Konings WN, Higgins CF: A bacterial antibiotic-resistance gene that complements the human multidrug-resistance P-glycoprotein gene. Nature 1998, 391:291-295. LmrA of L. lactis is a multidrug efflux pump homologous to one-half of the human multidrug transporter MDR1 or P-glycoprotein. This interesting study shows that when the ImrA gene is expressed in a human fibroblast line, the product not only goes to the plasma membrane, but also is fully functional in the extrusion of typical substrates of P-glycoprotein. Since expression of P-glycoprotein in bacteria is difficult, this system may serve as an ideal model system for future studies of P-glycoprotein.
8. Paulsen IT, Brown MH, Skurray RA: Proton-dependent multidrug efflux systems. Microbiol Rev 1996, 60:575-608
9. Pao SS, Paulsen IT, Saier MH Jr: Major facilitator superfamily. Microbiol Mol Biol Rev 1998, 62:1-34.
10. Schuldiner S, Shirvan A, Linial M: Vesicular neurotransmitter transporters: from bacteria to humans. Physiol Rev 1995, 75:369-392.
11. Paulsen IT, Skurray RA, Tam R, Saicr MH Jr, Turner RJ, Weiner JH, Goldberg EB, Grinius LL; The SMR family: A novel family of multidrug efflux proteins involved with the efflux of lipophilic drugs. Mol Microbiol 1996, 19:1167-1175.
12. Yerushalmi H, Lebendiker M, Schuidiner S: Negative dominance studies demonstrate the oligomeric structure of EmrE, a multidrug antiporter from Escherichia coli. J Biol Chem 1996, 271:31044-31048.
13. Saier MH Jr, Tam R, Reizer A, Reizer J: Two novel families of bacterial membrane proteins concerned with nodulation, cell division and transport. Mol Microbiol 1994, 11:841-847.
14. Ma D, Cook DN, Alberti M, Pon NG Nikaido H, Hearst JE: Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J Bacteriol 1993, 175:6299-6313.
15. Fralick JA: Evidence that ToIC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J Bacteriol 1996, 178:5803-5805.
16. Poole K, Krebes K, McNally C, Neshat S: Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol 1993, 175:7363-7372.
17. Hagman KE, Pan W, Spratt BG, Balthazar JT, Judd RC, Shafer WM: Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrCDE efflux system. Microbiology 1995, 141:611-622.
18. Sanchez L, Pan W, Vinas M, Nikaido H: The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol 1997, 179:6855-6857.
19. Baranova NN, Neyfakh AA: Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 1997, 41:1396-1398.
20. Zeller V, Janoir C, Kitzis M-D, Gutmann L, Moreau NJ: Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother 1997, 41:1973-1978.
21. Miyamae S, Nikaido H, Tanaka Y, Yoshimura F: Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob Agents Chemother 1998, 42:2119-2121.
22. Alonso A, Martinez JL: Multiple antibiotic resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother 1997, 41:1140-1142.
23. Woolridge DP, Vazquez-Laslop N, Markham PN, Chevalier MS, Gerner EW, Neyfakh AA: Efflux of the natural polyamine spermidine facilitated by the Bacillus subtilis multidrug transporter Bit. J Biol Chem 1997, 272:8864-8866. The authors found that the blt gene, coding for an MFS (major facilitator superfamily) drug pump, is a part of an operon, apparently involved in detoxification of polyammes. This role was deduced because another gene of the operon codes for a polyamine acetylase. Indeed, spermidine is pumped out by cells overproducing Bit.
24. Neyfakh AA: Natural functions of bacterial multidrug transporters. Trends Microbiol 1997, 5:309-313.
25. Paulsen IT, Brown MH, Littlejotin TG, Mitchell BA, Skurray RA: Multidrug resistance proteins OacA and QacB from Staphylococcus aureus: membrane topology and identification of residues involved in substrate specificity. Proc Natl Acad Sci USA 1996, 93:3630-3635
26. Ahmed M, Borsch CM, Neyfakh AA, Schuldiner S: Mutants of Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J Biol Chem 1993, 268:11086-11089.
27. Klyachko KA, Schuldiner S, Neyfakh AA: Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J Bacteriol 1997, 179:2189-2193.
28. Lebendiker M, Schuldiner: Identification of residues in the translocation pathway of EmrE, a multidrug antiporter from Escherichia coli. J Biol Chem 1996, 271:211 93-21199.
29. Grinius LL, Goldberg EB: Bacterial multidrug resistance is due to a single membrane protein which functions as a drug pump. J Biol Chem 1994, 269:29998-30004.
30. + and is soluble in organic solvents. J Biol Chem 1995, 270:6856-6863.
31. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, Sarkadi B: Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 1 993, 268:2149321496.
32. Ruetz S, Gros P: A phospholipid translocase: a physiological role for the mdr2 gene. Cell 1994, 77:1071-1081.
33. Bolhuis H, van Veen HW, Molenar D, Poolman B, Driessen AJM, Konings WN: Multidrug resistance in Lacfococcus lactis: Evidence for ATP-dependent drug extrusion from the inner leaflet of the cytoplasmic membrane. EMBO J 1996, 15:4239-4245.
34. Bolhuis H, van Veen HW, Brands JR, Putman M, Poolman B, Driessen AJM, Konings WN: Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J Biol Chem 1996, 271:24123-24128.
35. Thanassi DG, Suh GSB, Nikaido H: Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J Bacteriol 1995, 177:998-1007.
36. Li X-Z, Nikaido H, Poole K: Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995, 39:1948-1953.
37. Nikaido H, Basina M, Nguyen V, Rosenberg EY: Multidrug efflux pump AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side-chains, J Bacteriol 1998, 180: in press.
38. Masuda N, Gotoh N, Ohya S, Nishino T: Quantitative correlation between susceptibility and OprJ production in NfxB mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996, 40:909-913.
39. Köhler T, Michéa-Hazehpour M, Henze U, Gotoh N, Curty LK, Péchère JC: Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 1997, 23:345-354.
40. Plésiat P, Nikaido H: Outer membranes of Gram-negative bacteria are permeable to steroid probes. Mol Microbiol 1992, 6:1323-1333.
41. Thanassi D, Cheng LW, Nikaido H: Active efflux of bile salts by Escherichia coli. J Bacteriol 1997, 179:2512-2518.
42. Kramer UC, Nickerson KW: A transport-dependent energy burden imposed by growth of Enterobacter cloacae in the presence of 10% sodium dodecyl sulfate. Can J Microbiol 1984, 30:699-702.
43. Lomovskaya O, Lewis K, Matin A: EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J Bacteriol 1995, 177:2328-2334.
44. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE: Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 1995, 16:45-55.
45. Ma D, Alberti M, Lynch C, Nikaido H, Hearst JE: In the regulation of the acrAB genes of Escherichia coli by global stress signals, the local repressor AcrR plays a modulating role. Mol Microbiol 1996, 19:101-112.
46. Okusu H, Ma D, Nikaido H: AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J Bacteriol 1996, 178:306-308.
47. Alekshun MN, Levy SB: Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 1997, 41:2067-2075. MarA (and its homologs such as PqrA, RamA, and AarP in other enteric bacteria) is the major positive regulator of the expression of multidrug efflux pump AcrAB, and thus confers low level resistance to practically all antibacterial agents, except aminoglycosides. This masterful review describes the transcriptional regulation of the mar locus, as well as the probable clinical significance of this system.
48. Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB: Cross-resistance to fluoroquinolones in multiple-antibiotic resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 1989, 33:1318-1325.
49. Poole K, Gotoh N, Tsujimoto H, Zhao Q, Wada A, Yamasaki T, Neshat S, Yamagishi J, Li X-Z, Nishino T: Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol 1996, 21:713-724.
50. Poole K, Tetro K, Zhao Q, Neshat S, Heinrichs DE, Bianco N: Expression of he multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother 1996, 40:2021-2028.
51. Hagman KE, Shafer WM: Transcriptional control of the mtr efflux system of Neisseria gonorrhoeas. J Bacteriol 1995, 177:4162-4165.
52. Nikaido H: The role of outer membrane and efflux pumps in the resistance of Gram-negative bacteria. Can we improve drug access? Drug Resistance Updates 1998,1:93-98. Poor access of many antibacterial agents to targets in Gram-negative bacteria is assumed to be caused by the synergy between the outer membrane barrier and the chromosomally coded multidrug efflux process. If so, we should be able to improve dramatically the efficacy of these drugs either by increasing the nonspecific permeability of the outer membrane, or by inhibiting the pump. This review examines this prediction critically, with experimental data.
53. th Interscience Conference on Antimicrobial Agents and Chemotherapy: 1996 Sept 15-18; New Orleans. Washington, DC: American Society for Microbiology; 1996:41.
54. Köhler T, Michéa-Hazehpour M, Plésiat P, Kahr A-L, Péchére JC: Differential selection of multidrug efflux systems by quinolones in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997 41:2540-2543.
55. Williams RJ, Livermore DM, Lindridge MA, Said AA, Williams JD: Mechanism of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. J Med Microbiol 1984, 17:283-293.
56. Bert F, Lambert-Zechovsky N: Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 1996, 37:809-813.
57. Shafer WM, Balthazar JT, Hagman KE, Morse SE: Missense mutations that alter the DMA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to fecal lipids. Microbiology 1995, 141:907-911.
58. Maneewannakul K, Levy SB: Identification of mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 1996, 40:1695-1698.
59. Gutmann L, Williamson R, Moreau N, Kitzis MD, Collatz E, Acar JF, Goldstein FW: Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis 1985, 151:501-507.
60. Firth N, Skurray RA: Mobile elements in the evolution and spread of multiple-drug resistance in staphylococci. Drug Resistance Updates 1998, 1:49-58.
61. Hashmi ZS, Smith JMB: Outer membrane changes in quinolone-resistant Pseudomonas aeruginosa. J Antimicrob Chemother 1991, 28:465-470.
62. Piddock LJV, Hall MC, Bellido F, Bains M, Hancock REW: A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1992, 36:1057-1061.
63. Littlejohn TG, Paulsen IT, Gillepsie MT, Tennent JM, Midgley M, Jones IG, Purewal AS, Skurray RA: Substrate specificity and energetics of antiseptic and disinfectant resistance in Staphylococcus aureus. FEMS Microbiol Lett 1992, 95:259-266.
64. Liu J, Takiff HE, Nikaido H: Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump. J Bacteriol 1996, 178:3791-3795.
65. Neyfakh AA, Borsch CM, Kaatz GW: Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob Agents Chemether 1993, 37:128-129.
66. Neyfakh AA, Bidnenki VE, Chen LB: Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 1991, 88:4781-4785.
67. Lomovskaya O, Lewis K: emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci USA 1989, 89:8938-8942.
68. While DG, Goldman JD, Demple B, Levy SB: Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia colt. J Bacteriol 1997, 179:6122-6126. AcrAB, the major multidrug efflux pump of E. coli, is responsible for the extrusion of not only dyes, detergents, and antibiotics, but also organic solvents. Its homolog MexAB plays the same role in P. aeruginosa (see [70]).
69. Köhler T, Kok M, Michéa-Hazehpour M, Plésiat P, Gotoh N, Nishino T, Curty LK, Péchère JC: Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1996, 40:2288-2290.
70. Schweizer HP: Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob Agents Chemother 1998, 42:394-398.
71. Li X-Z, Zhang L, Poole K: Role of multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J Bacteriol 1998, 180:2987-2991.